Unity Biotechnology UBX
$ 1.16
-0.85%
Quarterly report 2024-Q3
added 11-04-2024
Unity Biotechnology Financial Ratios 2011-2024 | UBX
Annual Financial Ratios Unity Biotechnology
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -0.9 | -0.1 | -0.3 | -3.2 | -4.2 | - | -22.1 | - | - | - | - | - |
P/S |
- | 167.4 | 1.4 | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.7 | -4.7 | -10.9 | -18.4 | -1.9 | -2.7 | -14.0 | -11.4 | - | - | - | - | - |
EV (Enterprise Value) |
39.6 M | 95 M | 39 M | 86 M | 259 M | 328 M | 3.88 M | 719 M | - | - | - | - | - |
EBITDA per Share |
-2.94 | -5.83 | -9.64 | -17.8 | -2.02 | -2.57 | - | -0.222 | - | - | - | - | - |
EV/EBITDA |
-1.6 | -3.9 | -2.6 | -4.2 | - | -17.9 | - | - | - | - | - | ||
PEG |
- | -0.68 | -0.11 | 0.05 | - | 12.1 | - | - | - | - | - | ||
P/B |
0.8 | 0.7 | 0.1 | 0.4 | 2.2 | 2.0 | - | 7.5 | - | - | - | - | - |
P/CF |
-0.6 | -0.8 | -0.1 | -0.4 | -3.6 | -5.6 | - | -36.0 | - | - | - | - | - |
ROE % |
-140.36 | -79.29 | -101.94 | -113.23 | -68.08 | -47.54 | - | -33.95 | - | - | - | - | - |
ROA % |
-60.68 | -35.76 | -48.69 | -60.03 | -54.34 | -42.12 | - | -31.46 | - | - | - | - | - |
ROCE % |
-157.29 | -102.65 | -95.12 | -113.33 | -67.91 | -45.46 | - | -32.71 | - | - | - | - | - |
Current Ratio |
1.8 | 1.8 | 1.9 | 2.1 | 7.5 | 10.4 | - | 25.3 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Unity Biotechnology
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.38 | -0.31 | -0.34 | - | -1.01 | -1.07 | -0.37 | - | -1.36 | -1.9 | -2.8 | - | -2.97 | -0.32 | -0.29 | -0.37 | -0.52 | -0.38 | -0.59 | -0.39 | -0.51 | -0.56 | -0.44 | -0.53 | -0.45 | -0.76 | -4.69 | -3.67 | -3.63 | -3.62 | -2.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.44 | - | - | - | -0.71 | - | -1.13 | -1.59 | -2.61 | - | -2.28 | -0.28 | -0.26 | -0.35 | -0.42 | -0.43 | -0.55 | -0.49 | -0.48 | -0.55 | -0.45 | -0.54 | -0.43 | -0.75 | -4.65 | -2.65 | -3.47 | -3.59 | -2.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-150.00 | -157.49 | -168.68 | -101.12 | -118.57 | -82.70 | -77.69 | -87.66 | -116.15 | -127.20 | -121.34 | -75.24 | -98.87 | -103.63 | -99.11 | -113.23 | -104.53 | -89.27 | -86.36 | -68.08 | -66.78 | -60.22 | -53.05 | -47.54 | -18.81 | 6.74 | 32.94 | 53.73 | 38.64 | 24.50 | 10.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-54.79 | -62.38 | -67.82 | -41.26 | -51.31 | -40.02 | -38.18 | -40.33 | -53.42 | -56.45 | -56.08 | -36.80 | -49.33 | -53.87 | -52.73 | -60.03 | -59.42 | -56.16 | -59.87 | -54.34 | -54.51 | -50.26 | -45.64 | -42.12 | -42.33 | -43.73 | -43.91 | -43.77 | -31.47 | -19.96 | -8.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-166.28 | -172.19 | -165.92 | -101.44 | -118.15 | -82.27 | -83.91 | -83.45 | -109.13 | -118.10 | -113.18 | -70.16 | -92.82 | -96.87 | -99.26 | -113.33 | -109.80 | -98.59 | -90.69 | -74.27 | -69.34 | -62.88 | -55.55 | -49.45 | -19.87 | 6.72 | 33.74 | 54.87 | 39.49 | 24.95 | 10.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.6 | 1.7 | 1.8 | 2.1 | 2.0 | 2.0 | 2.2 | 2.4 | 1.7 | 1.8 | 1.9 | 1.9 | 1.9 | 2.2 | 2.1 | 2.1 | 2.1 | 2.1 | 5.0 | 5.0 | 5.0 | 5.0 | 8.8 | 8.8 | 8.8 | 8.8 | 9.1 | 9.1 | 9.1 | 9.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency